<VariationArchive VariationID="635151" VariationName="NM_203290.4(POLR1C):c.916_920del (p.Tyr306fs)" VariationType="Deletion" Accession="VCV000635151" Version="5" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-28" DateCreated="2019-07-22" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="622985" VariationID="635151">
      <GeneList>
        <Gene Symbol="POLR1C" FullName="RNA polymerase I and III subunit C" GeneID="9533" HGNC_ID="HGNC:20194" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="43517089" stop="44461400" display_start="43517089" display_stop="44461400" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="43484776" stop="43489250" display_start="43484776" display_stop="43489250" Strand="+" />
          </Location>
          <OMIM>610060</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_203290.4(POLR1C):c.916_920del (p.Tyr306fs)</Name>
      <CanonicalSPDI>NC_000006.12:43521039:ATTATAT:AT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="43521040" stop="43521044" display_start="43521040" display_stop="43521044" variantLength="5" positionVCF="43521039" referenceAlleleVCF="CATTAT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="43488778" stop="43488782" display_start="43488778" display_stop="43488782" variantLength="5" positionVCF="43488777" referenceAlleleVCF="CATTAT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>Y306fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.43488780_43488784del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.43488780_43488784del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.43521042_43521046del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.43521042_43521046del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_028283.3" sequenceAccession="NG_028283" sequenceVersion="3" change="g.16341_16345del">
            <Expression>NG_028283.3:g.16341_16345del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_051658.1" sequenceAccession="NG_051658" sequenceVersion="1" change="g.60032_60036del">
            <Expression>NG_051658.1:g.60032_60036del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318876.2" sequenceAccession="NM_001318876" sequenceVersion="2" change="c.916_920del">
            <Expression>NM_001318876.2:c.916_920del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305805.1" sequenceAccession="NP_001305805" sequenceVersion="1" change="p.Tyr306fs">
            <Expression>NP_001305805.1:p.Tyr306fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363658.2" sequenceAccession="NM_001363658" sequenceVersion="2" change="c.916_920del">
            <Expression>NM_001363658.2:c.916_920del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350587.1" sequenceAccession="NP_001350587" sequenceVersion="1" change="p.Tyr306fs">
            <Expression>NP_001350587.1:p.Tyr306fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_203290.4" sequenceAccession="NM_203290" sequenceVersion="4" change="c.916_920del" MANESelect="true">
            <Expression>NM_203290.4:c.916_920del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_976035.1" sequenceAccession="NP_976035" sequenceVersion="1" change="p.Tyr306fs">
            <Expression>NP_976035.1:p.Tyr306fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="767639108" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_203290.4(POLR1C):c.916_920del (p.Tyr306fs) AND Hypomyelinating leukodystrophy 11" Accession="RCV000788035" Version="3">
        <ClassifiedConditionList TraitSetID="22159">
          <ClassifiedCondition DB="MedGen" ID="C4225305">Hypomyelinating leukodystrophy 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_203290.4(POLR1C):c.916_920del (p.Tyr306fs) AND multiple conditions" Accession="RCV002487617" Version="1">
        <ClassifiedConditionList TraitSetID="47081">
          <ClassifiedCondition DB="MedGen" ID="C4225305">Hypomyelinating leukodystrophy 11</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1855433">Treacher Collins syndrome 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_203290.4(POLR1C):c.916_920del (p.Tyr306fs) AND not provided" Accession="RCV003727826" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-18" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2019-07-22" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30957429</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32042905</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">610060</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="47081" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33610" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypomyelinating leukodystrophy 11</ElementValue>
                <XRef ID="MONDO:0014666" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HLD11</ElementValue>
                <XRef Type="MIM" ID="616494" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">POLR3-related leukodystrophy, a hypomyelinating leukodystrophy with specific features on brain MRI, is characterized by varying combinations of four major clinical findings: Neurologic dysfunction, typically predominated by motor dysfunction (progressive cerebellar dysfunction, and to a lesser extent extrapyramidal [i.e., dystonia], pyramidal [i.e., spasticity] and cognitive dysfunctions). Abnormal dentition (delayed dentition, hypodontia, oligodontia, and abnormally placed or shaped teeth). Endocrine abnormalities such as short stature (in ~50% of individuals) with or without growth hormone deficiency, and more commonly, hypogonadotropic hypogonadism manifesting as delayed, arrested, or absent puberty. Ocular abnormality in the form of myopia, typically progressing over several years and becoming severe. POLR3-related leukodystrophy and 4H leukodystrophy are the two recognized terms for five previously described overlapping clinical phenotypes (initially described as distinct entities before their molecular basis was known). These include: Hypomyelination, hypodontia, hypogonadotropic hypogonadism (4H syndrome); Ataxia, delayed dentition, and hypomyelination (ADDH); Tremor-ataxia with central hypomyelination (TACH); Leukodystrophy with oligodontia (LO); Hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC). Age of onset is typically in early childhood but later-onset cases have also been reported. An infant with Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) was recently reported to have pathogenic variants in POLR3A on exome sequencing. Confirmation of this as a very severe form of POLR3-related leukodystrophy awaits replication in other individuals with a clinical diagnosis of Wiedemann-Rautenstrauch syndrome.</Attribute>
                <XRef ID="NBK99167" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18088" />
                <XRef ID="18088" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22855961</ID>
                <ID Source="BookShelf">NBK99167</ID>
              </Citation>
              <XRef ID="88637" DB="Orphanet" />
              <XRef ID="C4225305" DB="MedGen" />
              <XRef ID="MONDO:0014666" DB="MONDO" />
              <XRef Type="MIM" ID="616494" DB="OMIM" />
            </Trait>
            <Trait ID="5450" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Treacher Collins syndrome 3</ElementValue>
                <XRef ID="MONDO:0009558" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mandibulofacial dysostosis, Treacher Collins type, autosomal recessive</ElementValue>
                <XRef ID="Mandibulofacial+dysostosis%2C+Treacher+Collins+type%2C+autosomal+recessive/4444" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TCS3</ElementValue>
                <XRef Type="MIM" ID="248390" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Treacher Collins syndrome (TCS) is characterized by bilateral and symmetric downslanting palpebral fissures, malar hypoplasia, micrognathia, and external ear abnormalities. Hypoplasia of the zygomatic bones and mandible can cause significant feeding and respiratory difficulties. About 40%-50% of individuals have conductive hearing loss attributed most commonly to malformation of the ossicles and hypoplasia of the middle ear cavities. Inner ear structures tend to be normal. Other, less common abnormalities include cleft palate and unilateral or bilateral choanal stenosis or atresia. Typically intellect is normal.</Attribute>
                <XRef ID="NBK1532" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9125" />
                <XRef ID="9125" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301704</ID>
                <ID Source="BookShelf">NBK1532</ID>
              </Citation>
              <XRef ID="861" DB="Orphanet" />
              <XRef ID="C1855433" DB="MedGen" />
              <XRef ID="MONDO:0009558" DB="MONDO" />
              <XRef Type="MIM" ID="248390" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="22159" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33610" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypomyelinating leukodystrophy 11</ElementValue>
                <XRef ID="MONDO:0014666" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HLD11</ElementValue>
                <XRef Type="MIM" ID="616494" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">POLR3-related leukodystrophy, a hypomyelinating leukodystrophy with specific features on brain MRI, is characterized by varying combinations of four major clinical findings: Neurologic dysfunction, typically predominated by motor dysfunction (progressive cerebellar dysfunction, and to a lesser extent extrapyramidal [i.e., dystonia], pyramidal [i.e., spasticity] and cognitive dysfunctions). Abnormal dentition (delayed dentition, hypodontia, oligodontia, and abnormally placed or shaped teeth). Endocrine abnormalities such as short stature (in ~50% of individuals) with or without growth hormone deficiency, and more commonly, hypogonadotropic hypogonadism manifesting as delayed, arrested, or absent puberty. Ocular abnormality in the form of myopia, typically progressing over several years and becoming severe. POLR3-related leukodystrophy and 4H leukodystrophy are the two recognized terms for five previously described overlapping clinical phenotypes (initially described as distinct entities before their molecular basis was known). These include: Hypomyelination, hypodontia, hypogonadotropic hypogonadism (4H syndrome); Ataxia, delayed dentition, and hypomyelination (ADDH); Tremor-ataxia with central hypomyelination (TACH); Leukodystrophy with oligodontia (LO); Hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC). Age of onset is typically in early childhood but later-onset cases have also been reported. An infant with Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) was recently reported to have pathogenic variants in POLR3A on exome sequencing. Confirmation of this as a very severe form of POLR3-related leukodystrophy awaits replication in other individuals with a clinical diagnosis of Wiedemann-Rautenstrauch syndrome.</Attribute>
                <XRef ID="NBK99167" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18088" />
                <XRef ID="18088" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22855961</ID>
                <ID Source="BookShelf">NBK99167</ID>
              </Citation>
              <XRef ID="88637" DB="Orphanet" />
              <XRef ID="C4225305" DB="MedGen" />
              <XRef ID="MONDO:0014666" DB="MONDO" />
              <XRef Type="MIM" ID="616494" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1808258" SubmissionDate="2019-01-21" DateLastUpdated="2019-07-22" DateCreated="2019-07-22">
        <ClinVarSubmissionID localKey="NM_203290.3:c.916_920del|Leukodystrophy, hypomyelinating, 11" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000924610" DateUpdated="2019-07-22" DateCreated="2019-07-22" Type="SCV" Version="1" SubmitterName="MyeliNeuroGene Lab, McGill University Health Center Research Institute" OrgID="320379" OrganizationCategory="laboratory" OrgAbbreviation="MNG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">610060</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLR1C" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_203290.3:c.916_920del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Leukodystrophy, hypomyelinating, 11</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5043960</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5437286" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_203290.4:c.916_920del|OMIM:248390;616494" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002791382" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_203290.4:c.916_920del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="248390" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616494" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8324680" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="9692566|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004535416" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30957429</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32042905</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 635151). This premature translational stop signal has been observed in individual(s) with leukodystrophy and/or Treacher Collins syndrome (PMID: 30957429, 32042905). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs767639108, gnomAD 0.004%). This sequence change creates a premature translational stop signal (p.Tyr306Leufs*4) in the POLR1C gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 41 amino acid(s) of the POLR1C protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLR1C" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.43488778_43488782del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8324680" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5437286" TraitType="Disease" MappingType="XRef" MappingValue="248390" MappingRef="OMIM">
        <MedGen CUI="C1855433" Name="Treacher Collins syndrome 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1808258" TraitType="Disease" MappingType="Name" MappingValue="Leukodystrophy, hypomyelinating, 11" MappingRef="Preferred">
        <MedGen CUI="C4225305" Name="Hypomyelinating leukodystrophy 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5437286" TraitType="Disease" MappingType="XRef" MappingValue="616494" MappingRef="OMIM">
        <MedGen CUI="C4225305" Name="Hypomyelinating leukodystrophy 11" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

